Post-COVID conditions: a Portuguese primary care study


  • Tiago Gomes de Oliveira USF Barão Nova Sintra. Porto, Portugal.
  • Hugo Silva Almeida USF Barão Nova Sintra. Porto, Portugal.
  • Inês Baptista Pereira USF Barão Nova Sintra. Porto, Portugal.
  • Maria João Fernandes USF Barão Nova Sintra. Porto, Portugal.
  • Mariana Dias Almeida USF Barão Nova Sintra. Porto, Portugal.
  • Carlos Carvalho UMIB – Unidade Multidisciplinar de Investigação Biomédica, ICBAS – Instituto Ciências Biomédicas Abel Salazar. Porto, Portugal.
  • Ana Bessa Monteiro USF Barão Nova Sintra. Porto, Portugal.
  • Ana Filipa Belo USF Barão Nova Sintra. Porto, Portugal.



COVID-19, Post-acute COVID-19 syndrome, Post-COVID conditions, Long COVID


The Centers for Disease Control and Prevention propose the term long COVID or post-COVID conditions for symptoms that develop during or after COVID-19, continue for at least two months, and are not explained by an alternative diagnosis. In this cross-sectional study, we aimed at estimating the proportion of COVID-19 patients that presented post-COVID conditions, describing their baseline characteristics and main persisting symptoms. We included 497 adult patients who had recovered from mild to moderate COVID-19, using a structured questionnaire, 12 to 16 weeks after disease onset. The cumulative incidence for post-COVID conditions was 47.5% (n=236). The most frequent symptoms were fatigue (n=151, 30.4%) and dyspnea (n=131, 26.4%). After adjusting for covariables male gender was found to be associated with lower odds of post-COVID conditions (OR=0.36, p<0.001). Body Mass Index <20 (OR=0.28, p=0.014) and [30-35[ (OR=0.42, p=0.006) seemed to have less persistent symptoms when compared to [20-25[. No other baseline demographic or clinical features were found to be significantly associated with post-COVID conditions. Our study suggests that post-COVID conditions persist in a large subset of non-severe diseases. Physicians should continue to monitor these patients to identify and treat post-acute sequelae of SARS-CoV-2 infection, particularly in what concerns primary care.


Não há dados estatísticos.


Anaya JM, Rojas M, Salinas ML, Rodríguez Y, Roa G, Lozano M, et al. Post-COVID syndrome: a case series and comprehensive review. Autoimmun Rev. 2021;20(11):102947.

Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.

Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I; CoviCare Study Team. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021;174(9):1252-60.

World Health Organization. A clinical case definition of post-COVID-19 condition by a Delphi consensus, 6 October 2021 [homepage]. Geneva: WHO; 2021. Available from:

Digital Health Europe. TraceCovid [homepage]. Digital Health Europe; 2020 [cited 2021 Dec 10]. Available from:

George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009-16.

Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome: incidence and risk factors – a Mediterranean cohort study. J Infect. 2021;82(3):378-83.

Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737-54.




Como Citar

Gomes de Oliveira, T., Silva Almeida, H., Baptista Pereira, I., Fernandes, M. J., Dias Almeida, M., Carvalho, C., Bessa Monteiro, A., & Belo, A. F. (2023). Post-COVID conditions: a Portuguese primary care study. Revista Portuguesa De Medicina Geral E Familiar, 39(4), 351–4.